Sale!

Dengue Fever Combined Panel Test

910 د.إ

-10%

The Dengue Fever Combined Panel Test is a comprehensive diagnostic assessment offered at DNA Labs UAE, designed to accurately detect the presence of dengue fever in individuals. Priced at 910 AED, this panel test is an essential tool in the timely diagnosis and management of dengue fever, a mosquito-borne viral illness prevalent in tropical and subtropical regions worldwide.

The test combines several diagnostic methods to assess the presence of the dengue virus, antibodies produced in response to the virus (IgM and IgG antibodies), and other markers indicative of infection. This multifaceted approach enhances the accuracy of diagnosis, allowing for the differentiation between primary and secondary infections and providing crucial information on the stage of the disease.

Performed in the state-of-the-art facilities of DNA Labs UAE, the Dengue Fever Combined Panel Test ensures reliability and precision in results, aiding healthcare providers in making informed decisions regarding treatment plans. The comprehensive nature of this test makes it a valuable asset in the fight against dengue fever, contributing to better patient outcomes and the containment of outbreaks.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DENGUE FEVER COMBINED PANEL Test

Test Cost: AED 910.0

Symptoms, Diagnosis, and Test Details

The Dengue Fever Combined Panel Test is a diagnostic test used to detect the presence of antibodies or antigens associated with the dengue virus. Dengue fever is a mosquito-borne viral infection that can cause severe flu-like symptoms, including high fever, headache, joint and muscle pain, and rash. In some cases, it can lead to a more severe form of the disease called dengue hemorrhagic fever, which can be life-threatening.

The Dengue Fever Combined Panel Test combines multiple tests into one panel to provide a comprehensive analysis of dengue infection. It typically includes tests for dengue virus antigen (NS1 antigen) and dengue virus antibodies (IgM and IgG antibodies).

Test Components:

  • Dengue fever antibodies IgG & IgM
  • Dengue fever NS1 antigen

Price: AED 910.0

Sample Condition:

2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery:

Daily

Method:

ICT, Lateral Flow Immunochromatography

Test Type:

Fever

Doctor:

Physician

Test Department:

Pre Test Information: No special preparation required

Test Details:

The NS1 antigen test detects the presence of a specific viral protein produced by the dengue virus during the early stages of infection. This test is usually performed within the first week of symptom onset.

The IgM antibody test detects the presence of IgM antibodies, which are produced by the immune system in response to a dengue infection. IgM antibodies are usually detectable within 3-5 days after symptom onset and can persist for up to 3 months.

The IgG antibody test detects the presence of IgG antibodies, which are produced later in the course of infection and can persist for a longer period of time. IgG antibodies provide long-term immunity against dengue virus.

By combining these tests, the Dengue Fever Combined Panel Test can provide a more accurate diagnosis of dengue infection, especially when performed during the early stages of the disease. It can help differentiate between acute and past infections and provide information on the immune status of the individual.

It is important to note that the Dengue Fever Combined Panel Test is typically performed in a laboratory setting and requires a blood sample. The test results should be interpreted by a healthcare professional in conjunction with the individual’s clinical symptoms and other diagnostic tests, if necessary.

Test Name DENGUE FEVER COMBINED PANEL Test
Components *Dengue fever antibodies IgG & IgM*Dengue fever NS1 antigen
Price 910.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery Daily
Method ICT, Lateral Flow Immunochromatography
Test type Fever
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The Dengue Fever Combined Panel Test is a diagnostic test used to detect the presence of antibodies or antigens associated with the dengue virus.

Dengue fever is a mosquito-borne viral infection that can cause severe flu-like symptoms, including high fever, headache, joint and muscle pain, and rash. In some cases, it can lead to a more severe form of the disease called dengue hemorrhagic fever, which can be life-threatening.

The Dengue Fever Combined Panel Test combines multiple tests into one panel to provide a comprehensive analysis of dengue infection. It typically includes tests for dengue virus antigen (NS1 antigen) and dengue virus antibodies (IgM and IgG antibodies).

The NS1 antigen test detects the presence of a specific viral protein produced by the dengue virus during the early stages of infection. This test is usually performed within the first week of symptom onset.

The IgM antibody test detects the presence of IgM antibodies, which are produced by the immune system in response to a dengue infection. IgM antibodies are usually detectable within 3-5 days after symptom onset and can persist for up to 3 months.

The IgG antibody test detects the presence of IgG antibodies, which are produced later in the course of infection and can persist for a longer period of time. IgG antibodies provide long-term immunity against dengue virus.

By combining these tests, the Dengue Fever Combined Panel Test can provide a more accurate diagnosis of dengue infection, especially when performed during the early stages of the disease. It can help differentiate between acute and past infections and provide information on the immune status of the individual.

It is important to note that the Dengue Fever Combined Panel Test is typically performed in a laboratory setting and requires a blood sample. The test results should be interpreted by a healthcare professional in conjunction with the individual’s clinical symptoms and other diagnostic tests, if necessary.